Oncology Decoded

Science EN ↓ Epizody: 28

CancerNetwork® is excited to announce the launch of Oncology Decoded, a new podcast that will discuss scientific data and practical application in the world of oncology. Hosted by 2 leading experts in the field, Benjamin Garmezy, MD, and Manoj Bupathi, MD, MS, this podcast will cover cutting-edge topics and offer actionable insights to help improve patient outcomes.

Autor

Oncology Decoded

Kategorie

Science

Web podcastu

audioboom.com

Nejnovější epizoda

25. čvn 2026

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Nainstaluj zdarma Android téměř 10 mil. stažení · hodnocení 4,8 iOS už brzy

Epizody

3: Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma 07.03.2025 25:30

This episode of Oncology Decoded tackled the challenging landscape of non-clear cell renal cell carcinoma (nccRCC), a heterogeneous group of tumors representing about 20% to 25% of all kidney cancers. The episode provided expert insights into the diagnosis and management of this complex disease. Meet the panel discussants: Manojkumar Bupathi, MD, MS, executive co-chair of Genitourinary Cancer Re...

2: Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer 05.03.2025 26:21

When treating hormone-sensitive prostate cancer (mHSPC), one question can be, when is the right time to optimize or intensify therapy? In the latest Oncology Decoded podcast, genitourinary oncologists discuss the use of radiotherapy and define oligometastatic disease including preferred treatment options. The discussion took place during the 2025 ASCO Genitourinary Cancers Symposium. The expert p...

1: NIAGARA Study is the Forefront of Post-ASCO GU Discussion in Bladder Cancer 04.03.2025 33:13

During the 2025 ASCO Genitourinary Cancers Symposium, Oncology Decoded held their inaugural podcast with a live filming taking place at the conference. The first episode focused on bladder cancer specifically, neoadjuvant vs adjuvant therapy options and the use of cisplatin vs carboplatin. Meet the expert panel involved in the discussion: Manojkumar Bupathi, MD, MS, executive co-chair of Geni...